Engineered bacteria can deliver antiviral therapies, vaccines

Published on May 21, 2025

New research demonstrates how specially engineered bacteria taken orally can operate as a delivery system for vaccines and antiviral therapies.

Continue reading on website
Other news

New blood test shows superior sensitivity in detecting HPV-associated head and neck cancers

May 20, 2025
Head and neck cancer researchers are reporting the development and testing of HPV-DeepSeek, a novel liquid biopsy assay. In their new study, HPV-DeepSeek achieved 99% sensitivty and specifity for diagnosing HPV-associated head and neck cancers, outperforming standard of care methods. HPV causes about 70% of oropharyngeal cancers in the U.S., which are increasing in incidence faster than other head

HIV vaccine study uncovers powerful new antibody target

May 27, 2025
In the long battle to create an effective HIV vaccine, scientists have made a major leap forward. A new study shows that a series of vaccines can coax the immune system to produce powerful antibodies capable of blocking a wide range of HIV strains -- including those that are typically the hardest to stop.